The next meeting of the South Australian rheumatology journal club will be on Wednesday 21st July at 7pm. The topic will be rheumatoid arthritis and biosimilars.
The meeting will be held in virtual format via Zoom. Details about the link to the Zoom meeting will be distributed by email.
After the meeting the summary of the discussion will be posted to this page.
| Article | Access Options |
|---|---|
| Switching From Reference Adalimumab to SB5 (Adalimumab Biosimilar) in Patients With Rheumatoid Arthritis by ME Weinblatt et al June 6, 2018; Arthritis & Rheumatology; 70:832-840 | Journal website |
| Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate-to-Severe Rheumatoid Arthritis by ME Weinblatt et al January 1, 2018; Arthritis & Rheumatology; 70:40-48 | Journal website |
| Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis by A Rubbert-Roth et al October 15, 2020; N Engl J Med; 383;16 | Journal website |